David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments. David Mitchell, PharmD ...
I tend to work with people who feel stuck, overwhelmed, or disconnected—struggling with concerns related to anxiety, depression, trauma or life transitions—and are ready for change. Many people I see ...
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for ...
The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway. 259 Prospect ...
Discover expert insights, market forecasts, and best practices in our latest issue, crafted to empower financial advisors for success in the year ahead and beyond.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results